Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition • 09-14 May 2026

Digital Poster

Quantitative and Multimodal MRI Biomarkers Across Neurologic and Systemic Disorders

Back to the Program-at-a-Glance

Quantitative and Multimodal MRI Biomarkers Across Neurologic and Systemic Disorders
Digital Poster
Neuro B
Wednesday, 13 May 2026
Digital Posters Row H
14:35 - 15:30
Session Number: 567-04
No CME/CE Credit
This session brings together a variety of cutting edge work in neuroimaging.

  Figure 567-04-001.  Comparing accelerated encoding strategies for Multi-echo Gradient Echo Quantitative Imaging free of physiological artifacts
Eva Guzmán Chacón, Mojtaba Shafiekhani, Maxim Zaitsev, Berkin Bilgic, Marcel Zwiers, Martijn Cloos, David Norris, José Marques
Donders Centre for Cognitive Neuroimaging, Radboud University, Nijmegen, Netherlands
Impact: We aim to test acceleration and physiological noise (cardiac and respiratory) mitigation strategies in an open source multi-echo GRE sequence geared towards R2* mapping, Quantitative Susceptibility Mapping (QSM) and Multi-compartment Relaxometry Myelin Water Imaging (MWI), using conventional 3T clinical hardware.
  Figure 567-04-002.  White Matter Damage in Temporal Lobe Epilepsy with Hippocampal Sclerosis: A NODDI and Automated Segmentation Study
Jinqin Li, Bing Chen, Dengyan Song, Zhuo Wang, Yuanyuan wei, Hao Ye, Guangxu Han
The First Clinical Medical College of Ningxia Medical University, Yinchuan, China
Impact: This study’s findings on WM volume reductions and NODDI metric alterations in TLE-HS patients can enhance surgical planning and prognosis, guiding clinicians in targeting epileptogenic regions more precisely and potentially improving patient outcomes.
  Figure 567-04-003.  Progressive Reorganization of Cortical Functional Connectivity Gradients in Non-Dialysis Patients With Chronic Kidney Disease
Siyuan Lu, Song'an Shang, Wenjin Liu, Daming Shen, Jing Ye
Northern Jiangsu People’s Hospital, Yangzhou, China
Impact: This study reveals early-onset hierarchical brain disruptions in CKD and their progressive aggravation with renal decline, providing insights into dynamic kidney–brain interactions and enabling stage-specific evaluation of cognitive vulnerability in non-dialysis patients.
  Figure 567-04-004.  Clinical head MR images in Finnish MR sites
Nea Pulkkinen, Henri Leskinen, Teija Sainio, Eveliina Lammentausta, Mikko Nissi, Jari Heikkinen
University of Eastern Finland, Kuopio, Finland
Impact: Analysis of clinical image quality done in a large setting in this study, gives insight into practices that provide better images. This can potentially lead to better clinical image quality on a national level, which undoubtedly improves patient care.
  Figure 567-04-005.  Selective Vulnerability of Left Fimbria in Cognitively Normal APOE ε4 Carriers: A Neuroimaging Signature of Preclinical AD
Yihan Suo, Luoyu Wang, Yuanyuan Zhao, Qi Feng, Zhongxiang Ding
Zhejiang Chinese Medical University, Hangzhou, China
Impact: This study indicate that the left fimbria may serve as a neuroimaging structure of preclinical Alzheimer's disease, offering insights into gene-brain-cognition pathways and informing strategies for early risk stratification and intervention in individuals at genetic risk for AD.
  Figure 567-04-006.  Rapid multiparametric quantitative MRI for predicting the activity of thyroid-associated ophthalmopathy
Yunmeng Wang, Yuanyuan Cui, Jiankun Dai, Tuo Li, Qingqing Wen, WeiYi Zhou, Yan Song, Yi Xiao
The Second Affiliated Hospital of Naval Medical University, Shanghai, China
Impact: Active and inactive TAO are differently treated in clinic. Accurately discriminating active from inactive TAO is important for treatment selection. Our study suggested the application of multiparametric quantitative MRI would be beneficial for guiding TAO treatment selection in clinical practice.
  Figure 567-04-007.  MRI-Based Prediction of Ischemic Stroke in Patients with Internal Carotid Artery Occlusion
qianqian wang, Min Tang, Kai AI
Impact: MRI-based Cox risk stratification flags high-risk ICAO patients early, prioritizing follow-up, intensifying antithrombotic therapy, and guiding revascularization.
  Figure 567-04-008.  The changes in the gray matter volume of the thalamus, hippocampus and amygdala in classic trigeminal neuralgia.
Danyang Wang, jingqi Jiang, Kai AI, Jing Zhang
Department of Magnetic Resonance, Lanzhou, China
Impact: Previous studies on the subregions of the thalamus, amygdala and hippocampus of CTN disease have been relatively scarce. The findings of this study are expected to provide a new direction for the exploration of clinical therapeutic targets.
  Figure 567-04-009.  High-resolution perfusion imaging of the human cerebral cortex with high-performance MRI
Meher Juttukonda, Jan Kufer, Hannah Weibley, Theodora Martin, Aneri Bhatt, Yulin Chang, Susie Huang
Massachusetts General Hospital, Boston, United States of America
Impact: Noninvasive perfusion imaging approaches with high-spatial resolution could help improve our understanding of cortical hemodynamic physiology at the laminar level, including how these effects may evolve in the aging brain.
  Figure 567-04-010.  Olfactory and Neurochemical Alterations Underlying Craving and Reward Dysregulation in Alcohol Use Disorder
Khushbu Agarwal, Siddharth Sarkar, Yatan Pal Singh Balhara
National Brain Research Center, Gurugram, India
Impact: Identifying olfactory and neurochemical biomarkers of craving can guide personalized, odor-based, non-invasive interventions to reduce relapse risk and improve emotional regulation in Alcohol Use Disorder.
  Figure 567-04-011.  Bundle-Resolved Orientation Dependence of White Matter T1 via Controlled Head Reorientation
Chun Liu, Zijian GAO, Ziqiang Yu, Ziqin Zhou, Qianxue Shan, Weitian Chen
The Chinese University of Hong Kong, Hong Kong, China
Impact: Demonstrating tract‑resolved angle effects on T1, provides references that help avoid misreading regional differences, and guide more consistent longitudinal interpretation, enabling more reliable application of T1 in clinical white‑matter tracts.

Back to the Program-at-a-Glance

© 2026 International Society for Magnetic Resonance in Medicine